Towards β-globin gene-targeting with integrase-defective lentiviral vectors

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Biotechnology Letters

• Publication date

  2010-07-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10529-010-0351-4PMID 20640481
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Update on thalassemia: clinical care and complications.

  2010cited by this paper
• Detection of unknown deletions in β‐globin gene cluster using relative quantitative PCR methods

  2009cited by this paper
• Integrase and integration: biochemical activities of HIV-1 integrase

  2008cited by this paper
• Gene therapy of inherited diseases.

  2008cited by this paper
• A novel transgenic mouse model produced from lentiviral germline integration for the study of β-thalassemia gene therapy

  2008influential reference
• Site-specific transfer of an intact beta-globin gene cluster through a new targeting vector.

  2007cited by this paper
• Gene delivery by lentivirus vectors

  2007cited by this paper
• Effective gene therapy with nonintegrating lentiviral vectors

  2006cited by this paper
• Production and purification of lentiviral vectors

  2006cited by this paper
• A novel single step double positive double negative selection strategy for beta-globin gene replacement.

  2006cited by this paper
• Transient gene expression by nonintegrating lentiviral vectors.

  2006cited by this paper
• Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo

  2006cited by this paper
• Homologous recombination and RecA protein: towards a new generation of tools for genome manipulations.

  2005cited by this paper
• A review of gene therapy for haematological disorders

  2005cited by this paper
• Gene Therapy for beta-thalassemia.

  2005cited by this paper
• Gene Therapy for beta-thalassemia.

  2005influential reference
• Progress toward the genetic treatment of the beta-thalassemias.

  2005cited by this paper
• Progress Toward the Genetic Treatment of the β‐Thalassemias

  2005cited by this paper
• Globin gene transfer for treatment of the β-thalassemias and sickle cell disease

  2004cited by this paper
• Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.

  2004cited by this paper
• Lentiviral Vectors

  2004cited by this paper
• Development of gene therapy for hematopoietic stem cells using lentiviral vectors

  2002cited by this paper
• Lentiviral Vectors

  2002cited by this paper
• Development of lentiviral vectors for gene therapy for human diseases.

  2000cited by this paper
• A rapid and efficient method for site-directed mutagenesis using one-step overlap extension PCR.

  1997cited by this paper
• Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells

  1995cited by this paper
• Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication

  1995cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper
• A 3' enhancer contributes to the stage-specific expression of the human beta-globin gene.

  1987influential reference

• The current applications of cell-free fetal DNA in prenatal diagnosis of single-gene diseases: A review

  2022cites this paper